sns-101
sensei biotherapeutics
['sensei']
this week at we re presenting preclinical data on sns-101, our conditionally active vista-blocking antibody, and characterization of vsig4, an immune checkpoint targeted by our discovery-stage sns-102 program. details: #sitc22 